Barilà, Gregorio
Quaglia, Francesca Maria
Furlan, Anna
Pescosta, Norbert
Bonalumi, Angela
Marcon, Chiara
Pascarella, Anna
Tinelli, Martina
De March, Elena
Lico, Albana
Sartori, Roberto
Clissa, Cristina
De Sabbata, Giovanni
Nappi, Davide
Porrazzo, Marika
De Marchi, Roberta
Pavan, Laura
Tosetto, Alberto
Gherlinzoni, Filippo
Krampera, Mauro
Bassan, Renato
Patriarca, Francesca
Semenzato, Gianpietro
Zambello, Renato
Funding for this research was provided by:
Università degli Studi di Padova
Article History
Received: 4 August 2023
Accepted: 5 September 2023
First Online: 20 September 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.The study was approved by the Institutional Review Board of Azienda Ospedaliera di Padova (2491P, PD-MM-REG1).
: Informed consent was obtained from all individual participants included in the study.
: GB has received honoraria from Amgen, Glaxo-Kline Smith, and Janssen-Cilag, has served on the advisory boards for Bristol-Myers Squibb and Janssen and has received consultancy fees from Janssen. FMQ has served on the advisory boards for AstraZeneca and Janssen-Cilag, has received speaker fees for Janssen-Cilag and consultancy fees for Sandoz. LP has served on the advisory board of Takeda. GS has received speaker, advisory board, or consultancy fees and/or research grants from Novartis, Takeda, Roche, Janssen-Cilag. RZ has served on advisory board for Amgen, Takeda, Bristol-Myers Squibb, Janssen-Cilag, Sanofi and Pfizer. All the other authors have no relevant financial or non-financial interests to disclose.